The World Health Organization on Friday issued an emergency use listing to Serum Institute of India’s version of Novavax Inc.’s COVID-19 vaccine, paving the way for the two companies to ship their doses for the COVAX program.
The EUL to the shot, Covovax, marks a significant milestone for Novavax as well, after the vaccine had been caught up with delays, especially in ramping up production. Shares of Novavax were up 6.4 percent on the news.
